Last reviewed · How we verify
NCT04350775
Investigation of Community Reablement on Instrumental Activities of Daily Living in People With Schizophrenia
NA trial testing RE-IADL in Schizophrenia in 80 participants. Completed in 6 July 2022.
6 July 2022
Quick facts
| Lead sponsor | National Taipei University of Nursing and Health Sciences |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 30 November 2021 |
| Primary completion | 6 July 2022 |
| Estimated completion | 6 July 2022 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- RE-IADL
- General community rehabilitation
Conditions studied
- Schizophrenia — all drugs for Schizophrenia →
Sponsor
National Taipei University of Nursing and Health Sciences
Who can join
Adults 20 to 99, any sex, with Schizophrenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomized controlled behavioral intervention trial to assess the efficacy of investigating program of Reablement-Instrumental Activities of Daily Living (RE-IADL) on schizophrenia patients at immediately and long-term.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04350775
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Schizophrenia
Currently open trials in the same condition.
- NCT07424404 — A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au · Phase 3 · recruiting
- NCT07467993 — Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia · Phase 2 · recruiting
- NCT07379827 — Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) · recruiting
- NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
- NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting
Other National Taipei University of Nursing and Health Sciences trials
Trials by the same sponsor.
- NCT07586696 — Effects of Exercise Board Games on Cognitive Function in Older Adults · NA · active not recruiting
- NCT07243717 — Information-Assisted Intervention for Potential Living Kidney Donors · NA · recruiting
- NCT07302568 — Exercise and Gezaixi Interventions on Community-Dwelling Older Adults · NA · completed
- NCT07196488 — Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses · NA · recruiting
- NCT07086261 — Using SRT to Improve The Drinking Problem Behavior of Elderly People With Dementia During The Care of Day Care · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04350775 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Taipei University of Nursing and Health Sciences
- Last refreshed: 1 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04350775.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing